Evidence map›Paper›PMID 23973461›Full record

ArticleBiochemical and biophysical research communications2013

RNF38 encodes a nuclear ubiquitin protein ligase that modifies p53.

Jamie E Sheren, C Kenneth Kassenbrock

Open access · hybridAbstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. p53: The Multifaceted Roles of Covalent Modifications in Cancer.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  5. Article
  6. A comparative assessment ofInternational journal of reproductive biomedicine · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Jamie E SherenDepartment of Pathology, The University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
C Kenneth Kassenbrock
Colorado State University · USUniversity of Colorado Anschutz Medical Campus · US

Funding

Regulation of Cellular Signaling Pathways by POSHR01NS052770 · NINDS · UNIVERSITY OF COLORADO DENVER · PI KASSENBROCK, CHARLES KENNETH · 2008 to 2012
$1.2M
NINDS NIH HHS R01 NS052770
6 · The paper itself

Abstract

The RNF38 gene encodes a RING finger protein of unknown function. Here we demonstrate that RNF38 is a functional ubiquitin protein ligase (E3). We show that RNF38 isoform 1 is localized to the nucleus by a bipartite nuclear localization sequence (NLS). We confirm that RNF38 is a binding partner of p53 and demonstrate that RNF38 can ubiquitinate p53 in vitro and in vivo. Finally, we show that overexpression of RNF38 in HEK293T cells results in relocalization of p53 to discrete foci associated with PML nuclear bodies. These results suggest RNF38 is an E3 ubiquitin ligase that may play a role in regulating p53.

Indexed as

Amino Acid SequenceCarrier ProteinsCell NucleusHEK293 CellsHumansIntranuclear Inclusion BodiesMolecular Sequence DataNuclear Localization SignalsNuclear ProteinsPromyelocytic Leukemia ProteinTranscription FactorsTumor Suppressor ProteinsUbiquitinationUbiquitin-Protein LigasesZinc FingersCarrier ProteinsNuclear Localization SignalsNuclear ProteinsPML protein, humanPromyelocytic Leukemia ProteinRNF38 protein, humanTranscription FactorsTumor Suppressor ProteinsUbiquitin-Protein LigasesE3p53PML nuclear bodiesRNF38Ubiquitin protein ligase

Identifiers

PMID23973461
PMCPMC3855391
OpenAlexW2086342716

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.